Answers are grounded in this paper and cite their sources.
Conventional immunoassays typically operate under equilibrium conditions and require several hours for accurate quantification, which limits their suitability for point-of-care testing (POCT). Here, we report a portable pre-equilibrium immunoassay that employs a microfluidic chip as a physical information interface to encode immunoreaction states, enabling artificial intelligence (AI)-based inference of equilibrium-referenced quantitative estimates from early-stage signal dynamics. Instead of waiting for equilibrium, transient target binding-induced motion trajectories of magnetic nanoparticle−loaded microbeads are monitored in a compact self-driven microfluidic system. The smartphone-integrated model predicts signal transduction outcomes from immunoreaction dynamics at individual time points, and quantitative analysis is achieved by jointly evaluating these time-resolved predictions, with an adversarial framework enhancing robustness. Using this approach, reliable quantification of real samples is achieved within 4 min, representing more than a 30-fold reduction in assay time compared with conventional enzyme-linked immunosorbent assay, while maintaining comparable sensitivity. By exploiting the kinetic information embedded within non-continuous, pre-equilibrium observations, this work provides a general strategy with broad potential to accelerate decentralized diagnostics.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: